Global Pediatric Orphan Drugs Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Pediatric Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Orphan Drugs.
The Pediatric Orphan Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pediatric Orphan Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Orphan Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Orphan Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Pediatric Orphan Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pediatric Orphan Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Orphan Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Recordati SpA
- Novartis
- Celgene
- Abbvie Inc.
- Orpharma
- Amgen Inc.
- Amryt Pharma Plc.
- Johnson & Johnson
- GSK Plc.
- Bristol-Myers Squibb Company
- Roche Holding
- Pfizer
- Sanofi
- Takeda
- Oncology Drugs
- Gastrointestinal Drugs
- Neurology Drugs
- Cardio-vascular Drugs
- Others
- Hospital Pharmacies
- Retail pharmacies
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Orphan Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Pediatric Orphan Drugs Market Perspective (2018-2029)
2.2 Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pediatric Orphan Drugs Players by Revenue
3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2018-2023)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Orphan Drugs Revenue
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2022
3.5 Pediatric Orphan Drugs Key Players Head office and Area Served
3.6 Key Players Pediatric Orphan Drugs Product Solution and Service
3.7 Date of Enter into Pediatric Orphan Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PEDIATRIC ORPHAN DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029)
5 PEDIATRIC ORPHAN DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pediatric Orphan Drugs Market Size (2018-2029)
6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pediatric Orphan Drugs Market Size by Country (2018-2023)
6.4 North America Pediatric Orphan Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Pediatric Orphan Drugs Market Size (2018-2029)
7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pediatric Orphan Drugs Market Size by Country (2018-2023)
7.4 Europe Pediatric Orphan Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2018-2029)
8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Pediatric Orphan Drugs Market Size (2018-2029)
9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023)
9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2018-2029)
10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Recordati SpA
11.1.1 Recordati SpA Company Detail
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.1.5 Recordati SpA Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 Abbvie Inc.
11.4.1 Abbvie Inc. Company Detail
11.4.2 Abbvie Inc. Business Overview
11.4.3 Abbvie Inc. Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.4.5 Abbvie Inc. Recent Development
11.5 Orpharma
11.5.1 Orpharma Company Detail
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.5.5 Orpharma Recent Development
11.6 Amgen Inc.
11.6.1 Amgen Inc. Company Detail
11.6.2 Amgen Inc. Business Overview
11.6.3 Amgen Inc. Pediatric Orphan Drugs Introduction
11.6.4 Amgen Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.6.5 Amgen Inc. Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Detail
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK Plc.
11.9.1 GSK Plc. Company Detail
11.9.2 GSK Plc. Business Overview
11.9.3 GSK Plc. Pediatric Orphan Drugs Introduction
11.9.4 GSK Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.9.5 GSK Plc. Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Detail
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.11.5 Roche Holding Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 Takeda
11.14.1 Takeda Company Detail
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.14.5 Takeda Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Pediatric Orphan Drugs Market Perspective (2018-2029)
2.2 Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pediatric Orphan Drugs Players by Revenue
3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2018-2023)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Orphan Drugs Revenue
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2022
3.5 Pediatric Orphan Drugs Key Players Head office and Area Served
3.6 Key Players Pediatric Orphan Drugs Product Solution and Service
3.7 Date of Enter into Pediatric Orphan Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PEDIATRIC ORPHAN DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029)
5 PEDIATRIC ORPHAN DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pediatric Orphan Drugs Market Size (2018-2029)
6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pediatric Orphan Drugs Market Size by Country (2018-2023)
6.4 North America Pediatric Orphan Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Pediatric Orphan Drugs Market Size (2018-2029)
7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pediatric Orphan Drugs Market Size by Country (2018-2023)
7.4 Europe Pediatric Orphan Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2018-2029)
8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Pediatric Orphan Drugs Market Size (2018-2029)
9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023)
9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2018-2029)
10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Recordati SpA
11.1.1 Recordati SpA Company Detail
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.1.5 Recordati SpA Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 Abbvie Inc.
11.4.1 Abbvie Inc. Company Detail
11.4.2 Abbvie Inc. Business Overview
11.4.3 Abbvie Inc. Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.4.5 Abbvie Inc. Recent Development
11.5 Orpharma
11.5.1 Orpharma Company Detail
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.5.5 Orpharma Recent Development
11.6 Amgen Inc.
11.6.1 Amgen Inc. Company Detail
11.6.2 Amgen Inc. Business Overview
11.6.3 Amgen Inc. Pediatric Orphan Drugs Introduction
11.6.4 Amgen Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.6.5 Amgen Inc. Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Detail
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK Plc.
11.9.1 GSK Plc. Company Detail
11.9.2 GSK Plc. Business Overview
11.9.3 GSK Plc. Pediatric Orphan Drugs Introduction
11.9.4 GSK Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.9.5 GSK Plc. Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Detail
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.11.5 Roche Holding Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 Takeda
11.14.1 Takeda Company Detail
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.14.5 Takeda Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Pediatric Orphan Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pediatric Orphan Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Market Share by Region (2018-2023)
Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Pediatric Orphan Drugs Market Share by Region (2024-2029)
Table 13. Pediatric Orphan Drugs Market Trends
Table 14. Pediatric Orphan Drugs Market Drivers
Table 15. Pediatric Orphan Drugs Market Challenges
Table 16. Pediatric Orphan Drugs Market Restraints
Table 17. Global Pediatric Orphan Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Pediatric Orphan Drugs Market Share by Players (2018-2023)
Table 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Table 20. Ranking of Global Top Pediatric Orphan Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatric Orphan Drugs Product Solution and Service
Table 24. Date of Enter into Pediatric Orphan Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Pediatric Orphan Drugs Revenue Market Share by Application (2018-2023)
Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Pediatric Orphan Drugs Revenue Market Share by Application (2024-2029)
Table 34. North America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 49. Recordati SpA Company Detail
Table 50. Recordati SpA Business Overview
Table 51. Recordati SpA Pediatric Orphan Drugs Product
Table 52. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 53. Recordati SpA Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Pediatric Orphan Drugs Product
Table 57. Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Celgene Company Detail
Table 60. Celgene Business Overview
Table 61. Celgene Pediatric Orphan Drugs Product
Table 62. Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Abbvie Inc. Company Detail
Table 65. Abbvie Inc. Business Overview
Table 66. Abbvie Inc. Pediatric Orphan Drugs Product
Table 67. Abbvie Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 68. Abbvie Inc. Recent Development
Table 69. Orpharma Company Detail
Table 70. Orpharma Business Overview
Table 71. Orpharma Pediatric Orphan Drugs Product
Table 72. Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 73. Orpharma Recent Development
Table 74. Amgen Inc. Company Detail
Table 75. Amgen Inc. Business Overview
Table 76. Amgen Inc. Pediatric Orphan Drugs Product
Table 77. Amgen Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 78. Amgen Inc. Recent Development
Table 79. Amryt Pharma Plc. Company Detail
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Pediatric Orphan Drugs Product
Table 82. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Pediatric Orphan Drugs Product
Table 87. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Plc. Company Detail
Table 90. GSK Plc. Business Overview
Table 91. GSK Plc. Pediatric Orphan Drugs Product
Table 92. GSK Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 93. GSK Plc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Detail
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product
Table 97. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Detail
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Pediatric Orphan Drugs Product
Table 102. Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Pfizer Company Detail
Table 105. Pfizer Business Overview
Table 106. Pfizer Pediatric Orphan Drugs Product
Table 107. Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Sanofi Company Detail
Table 110. Sanofi Business Overview
Table 111. Sanofi Pediatric Orphan Drugs Product
Table 112. Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Takeda Company Detail
Table 115. Takeda Business Overview
Table 116. Takeda Pediatric Orphan Drugs Product
Table 117. Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 118. Takeda Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Pediatric Orphan Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pediatric Orphan Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Market Share by Region (2018-2023)
Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Pediatric Orphan Drugs Market Share by Region (2024-2029)
Table 13. Pediatric Orphan Drugs Market Trends
Table 14. Pediatric Orphan Drugs Market Drivers
Table 15. Pediatric Orphan Drugs Market Challenges
Table 16. Pediatric Orphan Drugs Market Restraints
Table 17. Global Pediatric Orphan Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Pediatric Orphan Drugs Market Share by Players (2018-2023)
Table 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Table 20. Ranking of Global Top Pediatric Orphan Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatric Orphan Drugs Product Solution and Service
Table 24. Date of Enter into Pediatric Orphan Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Pediatric Orphan Drugs Revenue Market Share by Application (2018-2023)
Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Pediatric Orphan Drugs Revenue Market Share by Application (2024-2029)
Table 34. North America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 49. Recordati SpA Company Detail
Table 50. Recordati SpA Business Overview
Table 51. Recordati SpA Pediatric Orphan Drugs Product
Table 52. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 53. Recordati SpA Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Pediatric Orphan Drugs Product
Table 57. Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Celgene Company Detail
Table 60. Celgene Business Overview
Table 61. Celgene Pediatric Orphan Drugs Product
Table 62. Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Abbvie Inc. Company Detail
Table 65. Abbvie Inc. Business Overview
Table 66. Abbvie Inc. Pediatric Orphan Drugs Product
Table 67. Abbvie Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 68. Abbvie Inc. Recent Development
Table 69. Orpharma Company Detail
Table 70. Orpharma Business Overview
Table 71. Orpharma Pediatric Orphan Drugs Product
Table 72. Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 73. Orpharma Recent Development
Table 74. Amgen Inc. Company Detail
Table 75. Amgen Inc. Business Overview
Table 76. Amgen Inc. Pediatric Orphan Drugs Product
Table 77. Amgen Inc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 78. Amgen Inc. Recent Development
Table 79. Amryt Pharma Plc. Company Detail
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Pediatric Orphan Drugs Product
Table 82. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Pediatric Orphan Drugs Product
Table 87. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Plc. Company Detail
Table 90. GSK Plc. Business Overview
Table 91. GSK Plc. Pediatric Orphan Drugs Product
Table 92. GSK Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 93. GSK Plc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Detail
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product
Table 97. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Detail
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Pediatric Orphan Drugs Product
Table 102. Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Pfizer Company Detail
Table 105. Pfizer Business Overview
Table 106. Pfizer Pediatric Orphan Drugs Product
Table 107. Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Sanofi Company Detail
Table 110. Sanofi Business Overview
Table 111. Sanofi Pediatric Orphan Drugs Product
Table 112. Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Takeda Company Detail
Table 115. Takeda Business Overview
Table 116. Takeda Pediatric Orphan Drugs Product
Table 117. Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 118. Takeda Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Pediatric Orphan Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pediatric Orphan Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oncology Drugs Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Neurology Drugs Features
Figure 6. Cardio-vascular Drugs Features
Figure 7. Others Features
Figure 8. Global Pediatric Orphan Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Pediatric Orphan Drugs Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Pediatric Orphan Drugs Report Years Considered
Figure 14. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pediatric Orphan Drugs Market Share by Region: 2022 VS 2029
Figure 17. Global Pediatric Orphan Drugs Market Share by Players in 2022
Figure 18. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2022
Figure 20. North America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 22. United States Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 26. Germany Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2018-2029)
Figure 34. China Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 42. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 46. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 50. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 51. Abbvie Inc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 52. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 53. Amgen Inc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 54. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 56. GSK Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 58. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 61. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Global Pediatric Orphan Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pediatric Orphan Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oncology Drugs Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Neurology Drugs Features
Figure 6. Cardio-vascular Drugs Features
Figure 7. Others Features
Figure 8. Global Pediatric Orphan Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Pediatric Orphan Drugs Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Pediatric Orphan Drugs Report Years Considered
Figure 14. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pediatric Orphan Drugs Market Share by Region: 2022 VS 2029
Figure 17. Global Pediatric Orphan Drugs Market Share by Players in 2022
Figure 18. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2022
Figure 20. North America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 22. United States Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 26. Germany Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2018-2029)
Figure 34. China Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 42. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2018-2029)
Figure 46. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 50. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 51. Abbvie Inc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 52. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 53. Amgen Inc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 54. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 56. GSK Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 58. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 61. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
